A detailed history of Harbour Capital Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Harbour Capital Advisors, LLC holds 8,264 shares of NVO stock, worth $1.16 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
8,264
Previous 8,164 1.22%
Holding current value
$1.16 Million
Previous $844,000 25.71%
% of portfolio
0.27%
Previous 0.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

BUY
$102.11 - $135.92 $10,211 - $13,591
100 Added 1.22%
8,264 $1.06 Million
Q4 2023

Jan 05, 2024

BUY
$87.78 - $105.45 $3,072 - $3,690
35 Added 0.43%
8,164 $844,000
Q3 2023

Oct 05, 2023

BUY
$90.94 - $199.54 $537,000 - $1.18 Million
5,905 Added 265.51%
8,129 $739,000
Q2 2023

Jul 10, 2023

BUY
$155.98 - $172.65 $346,899 - $383,973
2,224 New
2,224 $359,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $317B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Harbour Capital Advisors, LLC Portfolio

Follow Harbour Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbour Capital Advisors, LLC with notifications on news.